PA
RGEN icon

Pineridge Advisors’s Repligen RGEN Stock Holding History

Pineridge Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.68K Buy
+50
New +$6.07K ﹤0.01% 234

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Pineridge Advisors's RGEN Position: Q3 2025 in Review

Pineridge Advisors opened a new position in Repligen (RGEN) in Q3 2025: 50 shares worth $6.68K. The stake represents ﹤0.01% of the portfolio and ranks #234 among its holdings.

451 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Pineridge Advisors held 50 shares of Repligen worth $6.68K as of Q3 2025.
  • Repligen was a new Pineridge Advisors position in Q3 2025.
  • Repligen made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #234 holding.
  • 451 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.